Injective (INJ) is one of the strongest-performing altcoins this Monday as bullish sentiment spreads across the cryptocurrency market.
The token is trading above $13.60, lifted by renewed investor confidence following Bitcoin’s move above $105,000.
With macroeconomic optimism and progress on regulatory fronts contributing to broader market momentum, analysts say Bitcoin could challenge new all-time highs in the near term.
That backdrop is fueling capital rotation into altcoins, and projects like Injective are benefiting from rising speculative interest.
A layer-1 blockchain focused on decentralized finance and the tokenization of real-world assets, Injective continues to draw attention as narratives around scalability and use-case-driven growth gain traction.
Injective price keeps rising above $10
The price of Injective (INJ) climbed about 7% in the past 24 hours, rising alongside major altcoins such as Ethereum, BNB and Solana as they push through key levels.
INJ gained value after recently breaking the $10 threshold.
It is currently trading around $13.62. On May 12, 2025, the token reached a high of $14.29, the highest level since late February.
As prices rise, Injective’s market capitalization expanded to roughly $1.37 billion, while 24-hour trading volume remained modest at about $172 million.
Having climbed roughly 46% over the past seven days and 67% over the last 30 days, growing market interest could put bulls in the driver’s seat.
Bitcoin rally and RWA tokenization lift INJ
While the Bitcoin rally fuels broader market optimism, INJ’s price is also supported by strong institutional demand across the real-world asset (RWA) ecosystem.
Tokenization is a major tailwind for Injective, and recent research highlights how this sector is creating momentum for INJ.
Previous bullish cycles triggered booms in DeFi, play-to-earn gaming, meme coins and AI-related tokens.
Now, analysts say that while those areas continue to grow, the expanding RWA market is drawing attention to blockchains like Injective.
Injective’s network, designed to tokenize traditional assets such as equities, stablecoins and commodities, stands to benefit from that trend.
Investors evaluating opportunities in the space increasingly view Injective as a core platform.
Further progress in RWA adoption could amplify INJ’s price momentum.
Technical outlook for Injective price
From a technical perspective, the daily chart for INJ paints a bullish picture.
INJ chart from TradingView
The daily relative strength index (RSI) currently sits in overbought territory.
However, it is not so stretched as to eliminate upside potential for bulls.
If a pullback occurs, INJ is likely to find support around $11.05 and $10.22.
That scenario would align with the moving average convergence divergence (MACD) divergence, which shows a bullish crossover.
The MACD histogram points to rising momentum. If momentum continues, bulls will target $16, followed by $20.